See their transcript. Very impressive. 5% penetration is now seen at $750M global revenues. It was said in the webcast that these are very conservative assumptions. PA at 10% penetration is $1.5B product.
And, they are chasing new markets for their stronger dose.
Why did pozen management rape their shareholders in face of this so called good news? what a bunch of corrupt greedy white collar criminal types run this company....shareholders will not be rewarded for investing in this corrupt company....
Play, roger that. Not many stocks with the limited downside and hugh upside this baby has. Our market cap at $5 per share is 150 million, but take out the cash on hand and you're right, the market is at this price is placing about a 70m value on the product line itself. This is truly on of the great values in small pharma. I'm all in.
Hey stockguyone, would you mine explaining this a little more. New to investing, but own the stock. I just don't understand that technical mumob jumbo you are spitting our there. Would love and appreciate your help.